Twist Bioscience Corp (NASDAQ:TWST)

14.40
Delayed Data
As of May 26
 -0.56 / -3.74%
Today’s Change
11.46
Today|||52-Week Range
58.76
-39.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$822.9M

Company Description

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. Its products include genes, oligo pools, Next Generation Sequencing (NGS), variant libraries, synthetic controls, antibody discovery, and SARS-CoV-2 Tools. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.

Contact Information

Twist Bioscience Corp.
681 Gateway Boulevard
San Francisco California 94080
P:(800) 719-0671
Investor Relations:

Employees

Shareholders

Mutual fund holders69.67%
Other institutional36.21%
Individual stakeholders13.87%

Top Executives

Emily Marine LeproustChairman & Chief Executive Officer
Patrick J. FinnPresident & Chief Operating Officer
James M. ThorburnChief Financial Officer
Siyuan ChenChief Technology Officer
Nimisha SrivastavaSenior Vice President-Research & Development